<p>Aptose Biosciences Inc. has announced that it will hold a special meeting of shareholders on January 16, 2026. The meeting will be conducted online. Shareholders will consider and vote on a proposed plan of arrangement involving Aptose Biosciences Inc., HS North America Ltd., and Hanmi Pharmaceutical Co. Ltd. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptose Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-309635), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

APTO

<p>Aptose Biosciences Inc. will hold a special online shareholder meeting on January 16, 2026, to vote on a proposed plan of arrangement with HS North America Ltd. and Hanmi Pharmaceutical Co. Ltd. The announcement was made via EDGAR by Aptose Biosciences and is for informational purposes only.</p>

Aptose Biosciences Inc. Announces Date for Special Shareholder Meeting